Today: 29 April 2026
Linde stock edges higher as tech retreat drags Wall Street in thin year-end trade
29 December 2025
1 min read

Linde stock edges higher as tech retreat drags Wall Street in thin year-end trade

NEW YORK, December 29, 2025, 13:26 ET — Regular session

  • Linde shares rose about 0.3% as broader U.S. equities slipped.
  • Year-end trading volumes stayed light ahead of the New Year’s holiday market closure.
  • Investors are watching Fed minutes, jobless claims and Linde’s next earnings update.

Linde shares rose 0.3% to $426.07 in early afternoon trading on Monday, after moving between $423.65 and $427.29 in the session.

The industrial gases maker held up even as U.S. stocks dipped from record highs in thin, holiday-shortened trading — a setup that can exaggerate moves in individual names.

“It’s a very light trading week ahead; volume is low,” said Sam Stovall, chief investment strategist at CFRA Research in New York. He pointed to tax-loss harvesting — selling losing positions to offset capital-gains taxes — as one factor that can distort late-year flows. Reuters

The SPDR S&P 500 ETF Trust was down about 0.5%, with heavyweight technology and AI-linked shares leading the broader pullback, Reuters reported. Investors are also looking to minutes from the Federal Reserve’s prior meeting and weekly jobless claims later this week, with U.S. markets shut on Thursday for New Year’s Day.

Linde, the world’s largest industrial gases company, supplies oxygen, nitrogen and hydrogen to customers ranging from factories to hospitals, leaving the stock sensitive to shifts in industrial demand but often steadied by long-term supply contracts.

Peer Air Products & Chemicals edged higher as well, while the broader market stayed in the red.

The company’s investor website lists its most recent corporate update as its third-quarter results released on Oct. 31, leaving few fresh company-specific catalysts for the stock in Monday’s trade.

In that quarterly update, Linde forecast fourth-quarter adjusted earnings per share — a profit measure that strips out some one-off items — of $4.10 to $4.20, citing weaker volumes in Europe. It reaffirmed a full-year outlook for 5% to 6% growth in adjusted EPS, Reuters reported.

Investors are now focused on whether European volumes stabilize and how pricing and new project wins feed into 2026 guidance when Linde reports next.

Nasdaq’s earnings calendar estimates Linde will report again on Feb. 5.

Stock Market Today

  • John Hancock Multifactor Small Cap ETF (JHSC) Sees Unusual Volume Spike
    April 29, 2026, 1:20 PM EDT. The John Hancock Multifactor Small Cap ETF (JHSC) experienced an unusual surge in trading volume Wednesday afternoon, with over 732,000 shares changing hands versus its typical three-month average of 27,000. Despite heightened activity, JHSC shares dipped 0.8% on the day. Key components driving volume included Mara Holdings, which fell 6.3% on a hefty 16.8 million shares traded, and Transocean, down 0.4% on 12.4 million shares. Vita Coco led gains within the ETF, surging 20.4%, while Siteone Landscape Supply struggled, shedding 17.2%. The wide swings among key holdings highlight the mixed sentiment within this small-cap multifactor ETF.

Latest article

General Dynamics Corporation Stock Jumps After Submarine Orders, Gulfstream Jets Lift 2026 Outlook

General Dynamics Corporation Stock Jumps After Submarine Orders, Gulfstream Jets Lift 2026 Outlook

29 April 2026
General Dynamics raised its 2026 profit outlook after first-quarter earnings and revenue topped estimates, sending shares up 10.9% to $347.72. The company reported $1.4 billion in operating earnings and $13.5 billion in revenue, with Marine Systems revenue up 21% on submarine programs. Orders reached $26.6 billion, pushing backlog to $130.8 billion. General Dynamics ended the quarter with $3.7 billion in cash.
Teva Stock Jumps As Branded Drugs Start Carrying The Old Generics Giant

Teva Stock Jumps As Branded Drugs Start Carrying The Old Generics Giant

29 April 2026
Teva reported first-quarter adjusted earnings of 53 cents per share on $3.98 billion revenue, beating estimates as sales of Austedo, Ajovy, and Uzedy climbed. Shares jumped 11% in New York trading. The company agreed to buy Emalex Biosciences for $700 million upfront, adding a late-stage Tourette syndrome drug candidate. Global generics revenue fell 16% amid increased competition.
Silicon Motion Stock Jumps After Q1 Sales Double and AI Storage Outlook Tops Estimates

Silicon Motion Stock Jumps After Q1 Sales Double and AI Storage Outlook Tops Estimates

29 April 2026
Silicon Motion reported first-quarter revenue of $342.1 million, up 105% from a year earlier, and forecast second-quarter sales above Wall Street estimates. Shares rose $45.09 to $194.27 in New York trading. The company cited strong demand for embedded storage controllers and AI-related enterprise storage. CEO Wallace Kou said its MonTitan SSD controller platform will enter volume production this quarter.
Caterpillar stock slips in thin year-end trade as CEO discloses Form 4 award
Previous Story

Caterpillar stock slips in thin year-end trade as CEO discloses Form 4 award

BellRing Brands stock slides about 9% as legal probe notice hits and volatility returns
Next Story

BellRing Brands stock slides about 9% as legal probe notice hits and volatility returns

Go toTop